Can Levsin (hyoscyamine) be used to reduce airway secretions in a tracheostomy patient with thick mucus despite optimal humidification and suctioning?

Levsin (Hyoscyamine) for Tracheostomy Secretion Management

Levsin can help reduce airway secretions in tracheostomy patients, but it should not be your first-line approach—optimize humidification and mechanical clearance first, then consider anticholinergics like hyoscyamine as adjunctive therapy for excessive secretions that persist despite proper airway management.

Mechanism and FDA-Approved Indications

Hyoscyamine (Levsin) is an anticholinergic agent that "controls excessive pharyngeal, tracheal and bronchial secretions" and is FDA-approved as a "drying agent" 1. It works by inhibiting acetylcholine at postganglionic cholinergic receptors in exocrine glands, thereby reducing secretion production 1.

Clinical Application Algorithm

Step 1: Ensure Optimal Humidification First

Before considering anticholinergics, you must address the root cause of thick secretions:

• Adequate humidification is essential and should be standard care for all tracheostomy patients 2
• Recent evidence shows that active humidification devices significantly reduce sputum viscosity and complications (crust formation decreased from 54% to 4%, pulmonary infections from 54% to 4%) 3
• Active subglottic airway humidification reduces secretion viscosity by 64.58% compared to 9.52% with standard care 4

Step 2: Consider Hyoscyamine as Adjunctive Therapy

If secretions remain problematic despite optimal humidification:

• Use hyoscyamine for volume reduction, not viscosity management
• The drug reduces secretion production but does nothing to thin existing thick mucus
• Sublingual administration provides rapid absorption with effects occurring within 2-3.5 hours 1

Critical Caveats and Pitfalls

The Paradox You Must Avoid

Using hyoscyamine without adequate humidification can worsen your problem—reducing secretion volume while simultaneously drying the airway creates even thicker, more tenacious secretions that are harder to clear and increase risk of:

• Mucus plug formation and tube obstruction 5
• Crust formation
• Airway mucosal injury 3

Important Safety Considerations

• Heat prostration risk: Decreased sweating can lead to fever and heat stroke in warm environments 1
• CNS effects: May cause drowsiness, dizziness, blurred vision, confusion, or psychosis in sensitive individuals 1
• Contraindications: Avoid in patients with potential intestinal obstruction 1

Practical Implementation

If you decide to use hyoscyamine:

1. Ensure continuous humidification is optimized first (heated humidifier preferred over heat-moisture exchangers) 2
2. Maintain closed-circuit ventilation with in-line suction 6
3. Start hyoscyamine at standard dosing for secretion control
4. Monitor for tube obstruction more vigilantly—the combination of reduced volume and potential drying requires increased suctioning vigilance
5. Watch for anticholinergic side effects, especially in elderly patients

The Bottom Line

Hyoscyamine has a legitimate role as a "drying agent" per FDA labeling 1, but it treats secretion volume, not viscosity. In tracheostomy patients with thick mucus, your primary intervention must be aggressive humidification 2, 3, 4. Only after optimizing humidification should you consider adding hyoscyamine for patients with truly excessive secretion production that interferes with care despite proper airway management.